RELIEF CREAM 0,25% Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

relief cream 0,25%

iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - thiocolchicoside - cream (ΚΡΕΜΑ) - 0,25% - thiocolchicoside 2,5mg - various

RELIEF GEL.EXT.US 0,25% W/W Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

relief gel.ext.us 0,25% w/w

iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - thiocolchicoside - gel.ext.us (ΓΕΛΗ) - 0,25% w/w - thiocolchicoside 2,5mg - various

MYOLGIN® SOLU.TAB (4+1000)MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

myolgin® solu.tab (4+1000)mg/tab

nassington ltd, cyprus Ιπποκράτους 3Α,, 2006 Λευκωσία - thiocolchicoside; paracetamol - solu.tab (ΔΙΑΛΥΤΟ ΔΙΣΚΙΟ) - (4+1000)mg/tab - thiocolchicoside 4mg; paracetamol 1.000mg - thiocolchicoside, combinations

MYOLGIN® TAB (2+500)MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

myolgin® tab (2+500)mg/tab

nassington ltd, cyprus Ιπποκράτους 3Α,, 2006 Λευκωσία - thiocolchicoside; paracetamol - tab (ΔΙΣΚΙΟ) - (2+500)mg/tab - thiocolchicoside 2mg; paracetamol 500mg - thiocolchicoside, combinations

IMURAN 50MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

imuran 50mg film coated tablets

aspen pharma trading limited (0000009582) 3016 lake drive, citywest business campus, dublin 24, d24 x586 - azathioprine - film coated tablets - 50mg - azathioprine (0000446866) 50mg

AZATHIOPRINE/PHARMACHEMIE 50MG/VIAL LY.PD.INJ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

azathioprine/pharmachemie 50mg/vial ly.pd.inj

chemipharm Σ.Γ. ΝΤΕΤΣΑΒΕΣ & ΣΙΑ Ε.Ε. - azathioprine - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 50mg/vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Jayempi Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - Απόρριψη μοσχεύματος - Ανοσοκατασταλτικά - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

MUSCO-RIL INJ.SOL 4MG/2ML AMP Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

musco-ril inj.sol 4mg/2ml amp

opella healthcare greece ΜΟΝΟΠΡΟΣΩΠΗ Ε.Π.Ε. Δ.Τ. opella Λεωφ.Συγγρού 348, 17674 Καλλιθέα Αττικής 210.9001600, 210.9001740 - thiocolchicoside - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 4mg/2ml amp - thiocolchicoside 2mg - thiocolchicoside

MUSCO-RIL CAPS 4MG/CAP Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

musco-ril caps 4mg/cap

opella healthcare greece ΜΟΝΟΠΡΟΣΩΠΗ Ε.Π.Ε. Δ.Τ. opella Λεωφ.Συγγρού 348, 17674 Καλλιθέα Αττικής 210.9001600, 210.9001740 - thiocolchicoside - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 4mg/cap - thiocolchicoside 4mg - thiocolchicoside

IMURAN TAB 50MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

imuran tab 50mg/tab

ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - azathioprine - tab (ΔΙΣΚΙΟ) - 50mg/tab - azathioprine - azathioprine